Cookson Peirce & Co’s Standard BioTools LAB Stock Holding History

Cookson Peirce & Co’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-30,710	Closed	-$378K	–	149
2019 Q2	$378K	Sell	30,710 -23,490	-43%	-$299K	0.03%	130
2019 Q1	$720K	Sell	54,200 -7,950	-13%	-$83.8K	0.06%	90
2018 Q4	$536K	Buy	+62,150	New	+$484K	0.05%	106
2016 Q3	–	Sell	-13,575	Closed	-$123K	–	149
2016 Q2	$123K	Buy	+13,575	New	+$128K	0.02%	127

Other funds holding LAB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

EIP

Easterly Investment Partners Beverly, Massachusetts $1.31B AUM 18.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ICM

Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Cookson Peirce & Co's LAB Position: Q3 2019 in Review

Cookson Peirce & Co sold out of Standard BioTools (LAB) in Q3 2019, closing a stake of 30,710 shares — an estimated $378K sold.

Cookson Peirce & Co first reported a position in LAB in Q2 2016 and held it in 4 quarters. The position peaked at $720K in Q1 2019. 125 funds tracked by Wall St. Rank hold LAB as of Q3 2019.

Cookson Peirce & Co reported no remaining Standard BioTools position as of Q3 2019 after selling out during the quarter.
Cookson Peirce & Co sold 30,710 Standard BioTools shares in Q3 2019, an estimated $378K.
Cookson Peirce & Co first reported a position in Standard BioTools in Q2 2016 and held it in 4 quarters.
Cookson Peirce & Co's Standard BioTools position peaked at $720K in Q1 2019.
125 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2019.

Based on Cookson Peirce & Co's 13F filing for Q3 2019, filed 5 Nov 2019.